Report

src

Active Pharmaceutical Ingredients Market, By Type: (Innovative and Generic), By Type of Synthesis (Synthetic and Biotech), By Type Of Manufacturer (Captive and Merchant), By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain management, Respiratory Diseases, and Other Therapeutic Applications) Market - Growth, Future Prospects, Post COVID-19 Scenario 2020 - 2028

 Report Code
 Category
 Published Date
 Pages
 Format
MNR-1514
Pharmaceuticals
29 July 2021
212
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

Active pharmaceutical ingredients are the key components in any drug or medicine. These API molecules are an actual ingredient in the drug that acts or works against the medical condition. For instance, an active component to relieve pain is added to a painkiller that lowers the intensity of pain. These active pharmaceutical ingredients are produced from different raw materials that involve intense physical and chemical processes. Depending on the nature of API, different complex steps are utilized that involves range of advanced drug synthesis technologies. API is generally referred to as bulk pharmaceuticals, currently, the large concentration of active pharmaceutical ingredients producers are situated in the Asia Pacific region, particularly in China and India. Most of the pharmaceutical companies are focusing on outsourcing API manufacturing to these places, which offers the key benefit of eradicating the need for high investment in expensive manufacturing infrastructure and equipment which is also complicated to install and maintain.

However, the demand for drugs to treat chronic diseases in the young and aging population is expected to fuel the sales of active pharmaceutical ingredients. In addition, the increasing geriatric population in North America and Europe is primarily driving the active pharmaceutical ingredient market. Current COVID-19 pandemic conditions have a positive effect on the demand for API due to rising need for antibiotics.

The active pharmaceutical ingredients market is categorized based on type, type of synthesis, type of manufacturer, and therapeutic application. Major types of API include innovative and generic. Based on synthesis the API molecules are primarily divided as synthetic and biotech. In terms of manufacturing the API, the market is categorized into captive and merchant. Major therapeutic applications of API can be found in communicable diseases, oncology, diabetes, cardiovascular disease, pain management, and respiratory diseases.

Major players in the market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boehringer Ingelheim International GmbH, Bayer AG., Merck & Co., Inc. Cipla, Inc. Dr. Reddy’s Laboratories Ltd. Sun Pharmaceutical Industries Ltd. Sandoz International GmbH, etc.

Global Active Pharmaceutical Ingredients Market, By Type
Based on the type the global active pharmaceutical ingredients market is bifurcated into the following
  • Innovative
  • Generic
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Active Pharmaceutical Ingredients Value Share, By Type, 2019 & 2028(% Value)


In 2020, generic segment held the largest share by type. The segment held around 60% of the share in overall global market in 2020. Large patient expiration and continuing demand of existing drug is fueling the segment growth in overall market.

Global Active Pharmaceutical Ingredients Market, By Type of Synthesis
Based on the type of synthesis the global active pharmaceutical ingredients market is bifurcated into the following
  • Synthetic
  • Biotech
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Active Pharmaceutical Ingredients Value Share, By Type of Synthesis, 2019 & 2028(% Value)


In 2020, synthetic segment held the largest share of the market, the segment held around 79% share of the market. Large demand of chemically synthesized API in tablet and capsules are supporting for large share of the segment in overall market.

Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer
Based on the type of manufacturer the global active pharmaceutical ingredients market is bifurcated into the following
  • Captive
  • Merchant
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Active Pharmaceutical Ingredients Value Share, By Type of Manufacturer, 2019 & 2028(% Value)


In 2020, captive segment held the largest share of the market, the segment held around 60% share of the market in 2020. Large API manufacturing capacities of major pharmaceutical companies are contributing for large share of the segment in overall market.

Global Active Pharmaceutical Ingredients Market, By Therapeutic Application
Based on the therapeutic application the global active pharmaceutical ingredients market is bifurcated into the following
  • Communicable Diseases
  • Oncology
  • Diabetes
  • Cardiovascular Disease
  • Pain management
  • Respiratory Diseases
  • Other Therapeutic Applications
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Active Pharmaceutical Ingredients Value Share, By Therapeutic Application, 2019 & 2028(% Value)


In 2020, oncology segment held the largest share of the market, the segment held around 22% share of the market in 2020. Growing prevalence of cancer in developed as well as in developing countries are contributing for large share of the segment in overall market.

Global Active Pharmaceutical Ingredients Services Market, By Geography
Based on geography, the active pharmaceutical ingredients market is segmented into following:
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA
Below graph provides a comparative analysis of the value contribution for each of the segment for the years 2020 and 2028:

Active Pharmaceutical Ingredients Value Share, By Geography, 2019 & 2028(% Value)


In 2020, Asia pacific held the largest share in the active pharmaceutical ingredients services market, and is expected to register strong growth over the forecast period. Strong API manufacturing countries such as India and China are fueling the growth of the market in North America and Europe and are also expected to contribute significant revenue in the market over the forecast period.

Chapter 1    Preface
        1.1    Report Description
                1.1.1    Aim of the Report
                1.1.2    Report Target Audience
                1.1.3    Report Offering
        1.2    Research Scope
        1.3    Research Methodology
                1.3.1    Phase I – Secondary Research
                1.3.2    Phase II – Primary Research
                1.3.3    Phase III – Expert Panel Review
                1.3.4    Assumptions
                1.3.5    Top-Down and Bottom-Up Approach

Chapter 2    Executive Summary
        2.1    Market Snapshot: Global Active Pharmaceutical Ingredients Market
        2.2    Global Active Pharmaceutical Ingredients Market, By Type
        2.3    Global Active Pharmaceutical Ingredients Market, By Type of Synthesis
        2.4    Global Active Pharmaceutical Ingredients Market, By Therapeutic Application
        2.5    Global Active Pharmaceutical Ingredients Market, By Geography

Chapter 3    Market Dynamics
        3.1    Product and Market Insights
                3.1.1    Global Active Pharmaceutical Ingredients Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
        3.2    Market Dynamics
                3.2.1    Growth Drivers
                3.2.2    Market Restraints
                3.2.3    Impact Analysis of Drivers and Restraints
                3.2.4    COVID-19 Impact
        3.3    Attractive Investment Proposition
        3.4    Competitive Analysis
                3.4.1    Competitive Landscape in the Active Pharmaceutical Ingredients Market

Chapter 4    Global Active Pharmaceutical Ingredients Market Analysis, By Type
        4.1    Overview
        4.2    Innovative
                4.2.1    Global Innovative Market Value, 2018 – 2028, (US$ Mn)
        4.3    Generic
                4.3.1    Global Generic Market Value, 2018 – 2028, (US$ Mn)

Chapter 5    Global Active Pharmaceutical Ingredients Market Analysis, By Type of Synthesis
        5.1    Overview
        5.2    Synthetic
                5.2.1    Global Synthetic Market Value, 2018 – 2028, (US$ Mn)
        5.3    Biotech
                5.3.1    Global Biotech Market Value, 2018 – 2028, (US$ Mn)

Chapter 6    Global Active Pharmaceutical Ingredients Market Analysis, By Type of Manufacturer
        6.1    Overview
        6.2    Captive
                6.2.1    Global Captive Market Value, 2018 – 2028, (US$ Mn)
        6.3    Merchant
                6.3.1    Global Merchant Market Value, 2018 – 2028, (US$ Mn)

Chapter 7    Global Active Pharmaceutical Ingredients Market Analysis, By Therapeutic Application
        7.1    Overview
        7.2    Communicable Diseases
                7.2.1    Global Communicable Diseases Market Value, 2018 – 2028, (US$ Mn)
        7.3    Oncology
                7.3.1    Global Oncology Market Value, 2018 – 2028, (US$ Mn)
        7.4    Diabetes
                7.4.1    Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
        7.5    Cardiovascular Disease
                7.5.1    Global Cardiovascular Disease Market Value, 2018 – 2028, (US$ Mn)
        7.6    Pain management
                7.6.1    Global Pain management Market Value, 2018 – 2028, (US$ Mn)
        7.7    Respiratory Diseases
                7.7.1    Global Respiratory Diseases Market Value, 2018 – 2028, (US$ Mn)
        7.8    Other
                7.8.1    Global Other Market Value, 2018 – 2028, (US$ Mn)

Chapter 8    North America Active Pharmaceutical Ingredients Market Analysis
        8.1    Overview
        8.2    North America Active Pharmaceutical Ingredients Market Analysis, By Type, 2018 – 2028
                8.2.1    Market Analysis
        8.3    North America Active Pharmaceutical Ingredients Market Analysis, By Type of Synthesis, 2018 – 2028
                8.3.1    Market Analysis
        8.4    North America Active Pharmaceutical Ingredients Market Analysis, By Therapeutic Application, 2018 – 2028
                8.4.1    Market Analysis
        8.5    North America Active Pharmaceutical Ingredients Market Analysis, By Country, 2018 – 2028
                8.5.1    Market Analysis
                8.5.2    U.S.
                8.5.3    Canada

Chapter 9    Europe Active Pharmaceutical Ingredients Market Analysis
        9.1    Overview
        9.2    Europe Active Pharmaceutical Ingredients Market Analysis, By Type, 2018 – 2028
                9.2.1    Market Analysis
        9.3    Europe Active Pharmaceutical Ingredients Market Analysis, By Type of Synthesis, 2018 – 2028
                9.3.1    Market Analysis
        9.4    Europe Active Pharmaceutical Ingredients Market Analysis, By Therapeutic Application, 2018 – 2028
                9.4.1    Market Analysis
        9.5    Europe Active Pharmaceutical Ingredients Market Analysis, By Country, 2018 – 2028
                9.5.1    Market Analysis
                9.5.2    UK
                9.5.3    Germany
                9.5.4    France
                9.5.5    Rest of Europe

Chapter 10    Asia Pacific Active Pharmaceutical Ingredients Market Analysis
        10.1    Overview
        10.2    Asia Pacific Active Pharmaceutical Ingredients Market Analysis, By Type, 2018 – 2028
                10.2.1    Market Analysis
        10.3    Asia Pacific Active Pharmaceutical Ingredients Market Analysis, By Type of Synthesis, 2018 – 2028
                10.3.1    Market Analysis
        10.4    Asia Pacific Active Pharmaceutical Ingredients Market Analysis, By Therapeutic Application, 2018 – 2028
                10.4.1    Market Analysis
        10.5    Asia Pacific Active Pharmaceutical Ingredients Market Analysis, By Country, 2018 – 2028
                10.5.1    Market Analysis
                10.5.2    China
                10.5.3    Japan
                10.5.4    India
                10.5.5    Rest of Asia Pacific

Chapter 11    Latin America Active Pharmaceutical Ingredients Market Analysis
        11.1    Overview
        11.2    Latin America Active Pharmaceutical Ingredients Market Analysis, By Type, 2018 – 2028
                11.2.1    Market Analysis
        11.3    Latin America Active Pharmaceutical Ingredients Market Analysis, By Type of Synthesis, 2018 – 2028
                11.3.1    Market Analysis
        11.4    Latin America Active Pharmaceutical Ingredients Market Analysis, By Therapeutic Application, 2018 – 2028
                11.4.1    Market Analysis
        11.5    Latin America Active Pharmaceutical Ingredients Market Analysis, By Country, 2018 – 2028
                11.5.1    Market Analysis
                11.5.2    Mexico
                11.5.3    Brazil
                11.5.4    Rest of Latin America

Chapter 12    Middle East and Africa (MEA) Active Pharmaceutical Ingredients Market Analysis
        12.1    Overview
        12.2    MEA Active Pharmaceutical Ingredients Market Analysis, By Type, 2018 – 2028
                12.2.1    Market Analysis
        12.3    MEA Active Pharmaceutical Ingredients Market Analysis, By Type of Synthesis, 2018 – 2028
                12.3.1    Market Analysis
        12.4    MEA Active Pharmaceutical Ingredients Market Analysis, By Therapeutic Application, 2018 – 2028
                12.4.1    Market Analysis
        12.5    MEA Active Pharmaceutical Ingredients Market Analysis, By Country, 2018 – 2028
                12.5.1    Market Analysis
                12.5.2    GCC Countries
                12.5.3    South Africa
                12.5.4    Rest of MEA

Chapter 13    Company Profiles
        13.1    Pfizer, Inc.
                13.1.1    Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.2    Teva Pharmaceutical Industries Ltd.
                13.2.1    Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.3    Sanofi S.A.
                13.3.1    Sanofi S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.4    Boehringer Ingelheim International GmbH
                13.4.1    Boehringer Ingelheim International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.5    Bayer AG.
                13.5.1    Bayer AG.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.6    Merck & Co., Inc.
                13.6.1    Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.7    Cipla, Inc.
                13.7.1    Cipla, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.8    Dr. Reddy’s Laboratories Ltd.
                13.8.1    Dr. Reddy’s Laboratories Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.9    Sun Pharmaceutical Industries Ltd.
                13.9.1    Sun Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
        13.10    Sandoz International GmbH
                13.10.1    Sandoz International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)

 

List of Figures



FIG. 1    Global Active Pharmaceutical Ingredients Market: Research Methodology
FIG. 2    Top-Down and Bottom Up Approach
FIG. 3    Global Active Pharmaceutical Ingredients Market, By Type, 2020 (US$ Mn)
FIG. 4    Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2020 (US$ Mn)
FIG. 5    Global Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2020 (US$ Mn)
FIG. 6    Global Active Pharmaceutical Ingredients Market, By Geography, 2020 (US$ Mn)
FIG. 7    Global Active Pharmaceutical Ingredients Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 8    Attractive Investment Proposition
FIG. 9    Market Positioning of Key Active Pharmaceutical Ingredients Providers, 2020
FIG. 10    Global Active Pharmaceutical Ingredients Market Value Share, By Type, 2020 & 2028 (% Value)
FIG. 11    Global Innovative Market Value, 2018 – 2028, (US$ Mn)
FIG. 12    Global Generic Market Value, 2018 – 2028, (US$ Mn)
FIG. 13    Global Active Pharmaceutical Ingredients Market Value Share, By Type of Synthesis, 2020 & 2028 (% Value)
FIG. 14    Global Synthetic Market Value, 2018 – 2028, (US$ Mn)
FIG. 15    Global Biotech Market Value, 2018 – 2028, (US$ Mn)
FIG. 16    Global Active Pharmaceutical Ingredients Market Value Share, By Type of Manufacturer, 2020 & 2028 (% Value)
FIG. 17    Global Captive Market Value, 2018 – 2028, (US$ Mn)
FIG. 18    Global Merchant Market Value, 2018 – 2028, (US$ Mn)
FIG. 19    Global Active Pharmaceutical Ingredients Market Value Share, By Therapeutic Application, 2020 & 2028 (% Value)
FIG. 20    Global Communicable Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG. 21    Global Oncology Market Value, 2018 – 2028, (US$ Mn)
FIG. 22    Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG. 23    Global Cardiovascular Disease Market Value, 2018 – 2028, (US$ Mn)
FIG. 24    Global Pain management Market Value, 2018 – 2028, (US$ Mn)
FIG. 25    Global Respiratory Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG. 26    Global Other Market Value, 2018 – 2028, (US$ Mn)
FIG. 27    U.S. Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 28    Canada Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 29    UK Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 30    Germany Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 31    France Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 32    Rest of Europe Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 33    China Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 34    Japan Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 35    India Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 36    Rest of Asia Pacific Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 37    Mexico Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 38    Brazil Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 39    Rest of Latin America Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 40    GCC Countries Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 41    South Africa Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)
FIG. 42    Rest of MEA Active Pharmaceutical Ingredients Market Value, 2018 – 2028, (US$ Mn)

 

List of Tables



TABLE 1    Market Snapshot: Global Active Pharmaceutical Ingredients Market
TABLE 2    Impact Pointers
TABLE 3    Impact Analysis of Drivers and Restraints
TABLE 4    North America Active Pharmaceutical Ingredients Market Value, By Type, 2018 – 2028
TABLE 5    North America Active Pharmaceutical Ingredients Market Value, By Type of Synthesis, 2018 – 2028
TABLE 6    North America Active Pharmaceutical Ingredients Market Value, By Therapeutic Application, 2018 – 2028
TABLE 7    North America Active Pharmaceutical Ingredients Market Value, By Country, 2018 – 2028
TABLE 8    Europe Active Pharmaceutical Ingredients Market Value, By Type, 2018 – 2028
TABLE 9    Europe Active Pharmaceutical Ingredients Market Value, By Type of Synthesis, 2018 – 2028
TABLE 10    Europe Active Pharmaceutical Ingredients Market Value, By Therapeutic Application, 2018 – 2028
TABLE 11    Europe Active Pharmaceutical Ingredients Market Value, By Country, 2018 – 2028
TABLE 12    Asia Pacific Active Pharmaceutical Ingredients Market Value, By Type, 2018 – 2028
TABLE 13    Asia Pacific Active Pharmaceutical Ingredients Market Value, By Type of Synthesis, 2018 – 2028
TABLE 14    Asia Pacific Active Pharmaceutical Ingredients Market Value, By Therapeutic Application, 2018 – 2028
TABLE 15    Asia Pacific Active Pharmaceutical Ingredients Market Value, By Country, 2018 – 2028
TABLE 16    Latin America Active Pharmaceutical Ingredients Market Value, By Type, 2018 – 2028
TABLE 17    Latin America Active Pharmaceutical Ingredients Market Value, By Type of Synthesis, 2018 – 2028
TABLE 18    Latin America Active Pharmaceutical Ingredients Market Value, By Therapeutic Application, 2018 – 2028
TABLE 19    Latin America Active Pharmaceutical Ingredients Market Value, By Country, 2018 – 2028
TABLE 20    MEA Active Pharmaceutical Ingredients Market Value, By Type, 2018 – 2028
TABLE 21    MEA Active Pharmaceutical Ingredients Market Value, By Type of Synthesis, 2018 – 2028
TABLE 22    MEA Active Pharmaceutical Ingredients Market Value, By Therapeutic Application, 2018 – 2028
TABLE 23    MEA Active Pharmaceutical Ingredients Market Value, By Country, 2018 – 2028
TABLE 24    Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 25    Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 26    Sanofi S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 27    Boehringer Ingelheim International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 28    Bayer AG.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 29    Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 30    Cipla, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 31    Dr. Reddy’s Laboratories Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 32    Sun Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE 33    Sandoz International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)

 



 

No Methodology

No Available

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase